Clinical Application and Limitations of Non-Invasive Chromosomal Screening in Georgia

Common Patient Misconception: NIPT Can Replace All Chromosomal Tests

In clinical consultations, we often encounter patients who believe that non-invasive chromosomal screening (NIPT) can completely replace traditional amniocentesis or preimplantation genetic testing for aneuploidy (PGT-A). This understanding is biased. In fertility centers and prenatal diagnostic institutions in Georgia, NIPT is primarily used for screening fetal chromosomal numerical abnormalities, not for diagnosis. For individuals undergoing assisted reproductive treatment, especially those of advanced maternal age or at risk of chromosomal abnormalities, it is necessary to distinguish the applicable scenarios of NIPT and PGT-A.

Direct Answer: What is Non-Invasive Chromosomal Screening in Georgia

Non-invasive chromosomal screening in Georgia, commonly referred to as non-invasive prenatal testing (NIPT), involves collecting maternal peripheral blood to extract cell-free fetal DNA and detect whether the fetus has chromosomal aneuploidies. It mainly targets the following chromosomal abnormalities:

• Trisomy 21 (Down syndrome) — Detection accuracy approximately 99%
• Trisomy 18 (Edwards syndrome) — Detection accuracy approximately 97%
• Trisomy 13 (Patau syndrome) — Detection accuracy approximately 95%
• Sex chromosome abnormalities — Including Turner syndrome, Klinefelter syndrome, etc., accuracy approximately 90%

This method is non-invasive to the fetus and can be performed after 10 weeks of gestation. It is suitable for singleton and twin pregnancies. In Georgia, NIPT has been incorporated into the routine prenatal screening process of some fertility centers, but its screening nature must be clearly understood.

Why Has This Need Arisen

The main reasons for the increased demand for non-invasive chromosomal screening include:

• Increased proportion of advanced maternal age pregnancies — The risk of fetal chromosomal abnormalities is significantly higher in pregnant women over 35.
• Popularization of assisted reproductive technology — Individuals undergoing IVF treatment have higher concerns about embryo and fetal health.
• Avoiding risks of invasive procedures — Amniocentesis carries a 0.1%-0.3% risk of miscarriage, leading some patients to prefer non-invasive options.
• Maturation of screening technology — Next-generation sequencing has reduced the cost of NIPT and improved its accessibility.

Physician's Perspective: Clinical Positioning of NIPT in Georgia

The clinical consensus on NIPT in Georgian reproductive medicine centers is as follows:

Physicians generally recommend: NIPT is suitable for prenatal screening in low-risk populations. For individuals of advanced maternal age, those with a history of chromosomal abnormalities in previous pregnancies, or those with abnormal ultrasound soft markers, diagnostic testing should be performed directly.

Easily Overlooked Details: Limitations of NIPT

• False positives and false negatives — The false positive rate of NIPT for trisomy 21 is approximately 0.1%, but for sex chromosome abnormalities, it can reach 1%-2%.
• Confined placental mosaicism — The DNA detected by NIPT comes from the placenta, and there may be inconsistencies between placental and fetal chromosomes.
• Decreased accuracy in twin pregnancies — The accuracy of NIPT in twins is lower than in singletons, especially in monozygotic twins.
• Inability to detect structural abnormalities — NIPT only detects chromosomal numerical abnormalities and cannot identify microdeletions, microduplications, or single-gene disorders.
• Interference from maternal factors — Maternal chromosomal abnormalities, autoimmune diseases, or recent blood transfusions may affect results.

Common Pitfalls: Misunderstandings of NIPT in Assisted Reproduction

Individuals undergoing IVF treatment in Georgia often confuse NIPT with PGT-A. The most common cognitive errors are:

• Believing NIPT can replace PGT-A — NIPT is prenatal screening, while PGT-A is preimplantation screening. They act at different stages and cannot replace each other.
• Believing NIPT can detect all chromosomal abnormalities — NIPT mainly detects 5-7 types of chromosomal numerical abnormalities and has limited ability to detect microdeletions, balanced translocations, etc.
• Ignoring the screening nature of NIPT — Some patients think a low-risk NIPT result means the fetus is completely normal, neglecting the necessity of structural ultrasound examination.
• Choosing unregulated testing facilities — There are some uncertified testing services in Georgia, and the accuracy of their results cannot be guaranteed.

Actual Process: Steps for NIPT Testing in Georgia

1. Gestational age confirmation — Confirm via ultrasound that the pregnancy is at least 10 weeks; for twins, testing after 12 weeks is recommended.
2. Informed consent — The physician explains the screening nature, scope, and limitations of NIPT.
3. Peripheral blood collection — Draw 8-10 mL of maternal venous blood; fasting is not required.
4. Laboratory testing — Analyze cell-free fetal DNA using next-generation sequencing; the cycle takes approximately 7-10 business days.
5. Result interpretation — A genetic counselor or attending physician interprets the report; high-risk results recommend amniocentesis for confirmation.

Interpreting Test Indicators: How to Read an NIPT Report

NIPT reports issued by Georgian fertility centers typically include the following:

• Fetal chromosome Z-score — An absolute Z-score greater than 3 indicates high risk; between 2.5 and 3 is a gray zone.
• Fetal DNA concentration — Normal range is 4%-20%; too low a concentration may lead to test failure.
• Result classification — Low risk, high risk, borderline risk, or test failure.
• Recommendations — If high risk, the report will specify the abnormal chromosome and suggest follow-up actions.

Special note: Some NIPT reports include an "other chromosomal abnormality screening" option, but the positive predictive value for this item is low, and its clinical reference value is limited.

Frequently Asked Questions: What Patients Ask Most Often

Which is more accurate, NIPT or PGT-A?

They act at different stages. PGT-A is used for preimplantation screening of embryos, with an accuracy of about 95%-98%. NIPT is used for prenatal screening, with an accuracy of about 99% for trisomy 21. PGT-A cannot replace prenatal testing, and NIPT cannot replace embryo screening.

How much does NIPT cost in Georgia?

The cost of NIPT in Georgia is approximately 300-600 USD, depending on the testing scope (basic/advanced version) and the testing facility. Some fertility centers include NIPT in their prenatal care packages.

What should I do if my NIPT result is high risk?

A high-risk result does not mean the fetus is definitely abnormal. It is recommended to undergo amniocentesis or chorionic villus sampling under a physician's guidance for confirmatory chromosomal karyotype analysis. A detailed ultrasound structural screening should also be performed.

Do I still need NIPT after IVF pregnancy?

Yes. IVF pregnancies also carry a risk of chromosomal abnormalities. NIPT, as a prenatal screening method, is independent of the embryo transfer method. Even if PGT-A has been performed, NIPT and prenatal diagnosis are still recommended.

When is NIPT Suitable?

• Singleton or twin pregnancy with gestational age ≥ 10 weeks
• Routine prenatal screening for individuals without high risk of chromosomal abnormalities
• Low-risk pregnant women who decline invasive procedures like amniocentesis
• As a supplement or alternative to serum screening (e.g., triple screen)

When is NIPT Not Suitable?

• History of pregnancy or childbirth with chromosomal abnormalities
• Fetal structural abnormalities detected by ultrasound
• Vanishing twin or demise of one twin
• Maternal malignancy or active autoimmune disease
• Blood transfusion or organ transplant within the last 6 months

Practitioner Observation: Current Status of NIPT Application in Georgia

The adoption rate of NIPT in Georgian reproductive medicine centers is rising, but there are differences between centers. Some centers recommend NIPT as a routine prenatal screening item for all pregnant women, while others only recommend it for advanced maternal age or high-risk populations. Based on actual data, the issue of false positives in NIPT still requires clinicians to have strong interpretive skills to avoid unnecessary pregnancy terminations due to misinterpretation.

Additionally, the quality control standards of local testing facilities in Georgia vary. It is advisable to choose testing services that have international certifications (e.g., CAP, CLIA) or collaborate with well-known European laboratories. For individuals undergoing assisted reproduction, the interpretation of NIPT results should be combined with multidimensional information such as embryo screening history, age, and ultrasound indicators for comprehensive judgment.

Risk Reminder

Non-invasive chromosomal screening (NIPT) is a screening technology, not a diagnostic technology. All high-risk results must be confirmed by diagnostic testing before clinical decisions are made. When undergoing NIPT in Georgia, it is recommended to choose a fertility center with genetic counseling capabilities to ensure professional guidance before and after testing. Furthermore, NIPT cannot detect chromosomal structural abnormalities, single-gene disorders, or some mosaicisms and cannot replace systematic prenatal examinations.